bucillamine

Description

bucillamine · CAS 65002-17-7 · C7H13NO3S2. UNII R80LRA5WTF.

Identification

Computed Descriptors

Documented Uses

• Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
• Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
• M01 - Antiinflammatory and antirheumatic products
• M01C - Specific antirheumatic agents
• M01CC - Penicillamine and similar agents
• QM01 - Antiinflammatory and antirheumatic products

Synonyms

bucillamine; 65002-17-7; Tiobutarit; Bucilant; Bucilamina; N-(2-Mercapto-2-methylpropionyl)-L-cysteine; Bucillaminum; DTXSID2048587; R80LRA5WTF; SA-96; DE019; L-CYSTEINE, N-(2-MERCAPTO-2-METHYL-1-OXOPROPYL)-; (2R)-2-(2-METHYL-2-SULFANYLPROPANAMIDO)-3-SULFANYLPROPANOIC ACID; DTXCID2028513; RefChem:917687; M01CC02

Frequently Asked Questions

What are the CAS number and molecular formula of bucillamine?

CAS 65002-17-7; molecular formula C7H13NO3S2; molecular weight — g/mol.

What other names is bucillamine known by?

bucillamine, 65002-17-7, Tiobutarit, Bucilant, Bucilamina, N-(2-Mercapto-2-methylpropionyl)-L-cysteine.

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.